{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:58Z","timestamp":1787003638338,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H02833"],"award-info":[{"award-number":["JP22H02833"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Agency for Medical Research and Development,Japan","award":["JP19gm1210009"],"award-info":[{"award-number":["JP19gm1210009"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20zf0127003"],"award-info":[{"award-number":["JP20zf0127003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19dm0307102h0001"],"award-info":[{"award-number":["19dm0307102h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The lack of biomarkers to monitor and predict the efficacy of electroconvulsive therapy (ECT) has hindered its optimal use. To establish metabolomic markers for monitoring and predicting the treatment efficacy of ECT, we comprehensively evaluated metabolite levels in patients with major depressive disorder (MDD) by performing targeted and non-targeted metabolomic analyses using plasma samples before and after the first, third, and final ECT sessions, and 3\u20137\u00a0days after the final session. We compared the plasma metabolomes of age- and sex-matched healthy controls (HCs). Thirteen hospitalized patients with MDD and their corresponding HCs were included in this study. We observed that patients with MDD exhibited lower levels of amino acids, including gamma-aminobutyric acid (GABA), and metabolites involved in tryptophan metabolism and the kynurenine pathway, and higher levels of cortisol at baseline. Furthermore, we investigated the relationship between metabolite levels and depression severity across seven measurement timepoints along with one correlation analysis and found that amino acids, including GABA and tryptophan catabolites, were significantly correlated with the severity of depression. Despite the exploratory nature of this study due to the limited sample size necessitating further validation, our findings suggest that the blood metabolic profile has potential as a biomarker for ECT.<\/jats:p>","DOI":"10.1038\/s41598-023-40498-7","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T10:02:20Z","timestamp":1692007340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot study"],"prefix":"10.1038","volume":"13","author":[{"given":"Takahito","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji F.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"40498_CR1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917. https:\/\/doi.org\/10.1176\/ajp.2006.163.11.1905 (2006).","journal-title":"Am. J. Psychiatry"},{"issue":"9360","key":"40498_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/s0140-6736(03)12705-5","volume":"361","author":"UK Ect Review Group","year":"2003","unstructured":"UK Ect Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. The Lancet 361(9360), 799\u2013808. https:\/\/doi.org\/10.1016\/s0140-6736(03)12705-5 (2003).","journal-title":"The Lancet"},{"key":"40498_CR3","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jad.2017.10.008","volume":"227","author":"C Tunvirachaisakul","year":"2018","unstructured":"Tunvirachaisakul, C. et al. Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis. J. Affect Disord. 227, 164\u2013182. https:\/\/doi.org\/10.1016\/j.jad.2017.10.008 (2018).","journal-title":"J. Affect Disord."},{"key":"40498_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-016-0517-7","volume":"13","author":"L Schwieler","year":"2016","unstructured":"Schwieler, L. et al. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients. J. Neuroinflam. 13, 51. https:\/\/doi.org\/10.1186\/s12974-016-0517-7 (2016).","journal-title":"J. Neuroinflam."},{"key":"40498_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","volume":"48","author":"S Guloksuz","year":"2015","unstructured":"Guloksuz, S. et al. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Brain Behav. Immun. 48, 48\u201352. https:\/\/doi.org\/10.1016\/j.bbi.2015.02.029 (2015).","journal-title":"Brain Behav. Immun."},{"key":"40498_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jpsychires.2011.03.012","volume":"45","author":"M Vukadin","year":"2011","unstructured":"Vukadin, M., Birkenhager, T. K., Wierdsma, A. I., Groenland, T. H. & van den Broek, W. W. Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients. J. Psychiatr. Res. 45, 1165\u20131169. https:\/\/doi.org\/10.1016\/j.jpsychires.2011.03.012 (2011).","journal-title":"J. Psychiatr. Res."},{"key":"40498_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","volume":"15","author":"A Singh","year":"2017","unstructured":"Singh, A. & Kar, S. K. How electroconvulsive therapy works?: Understanding the neurobiological mechanisms. Clin. Psychopharmacol. Neurosci. 15, 210\u2013221. https:\/\/doi.org\/10.9758\/cpn.2017.15.3.210 (2017).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"40498_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ajmg.b.32680","volume":"180","author":"K MacDonald","year":"2019","unstructured":"MacDonald, K. et al. Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review. Am. J. Med Genet. B Neuropsychiatr. Genet. 180, 122\u2013137. https:\/\/doi.org\/10.1002\/ajmg.b.32680 (2019).","journal-title":"Am. J. Med Genet. B Neuropsychiatr. Genet."},{"key":"40498_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","volume":"73","author":"C Stetler","year":"2011","unstructured":"Stetler, C. & Miller, G. E. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosom. Med. 73, 114\u2013126. https:\/\/doi.org\/10.1097\/PSY.0b013e31820ad12b (2011).","journal-title":"Psychosom. Med."},{"key":"40498_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12888-020-02891-8","volume":"20","author":"JX Chen","year":"2020","unstructured":"Chen, J. X. et al. Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: A comparative cross-sectional study. BMC Psychiatry 20, 477. https:\/\/doi.org\/10.1186\/s12888-020-02891-8 (2020).","journal-title":"BMC Psychiatry"},{"key":"40498_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz, J. The kynurenine pathway: a finger in every pie. Mol. Psychiatry 25, 131\u2013147. https:\/\/doi.org\/10.1038\/s41380-019-0414-4 (2020).","journal-title":"Mol. Psychiatry"},{"key":"40498_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/s0033291712000955","volume":"43","author":"J Herbert","year":"2013","unstructured":"Herbert, J. Cortisol and depression: Three questions for psychiatry. Psychol. Med. 43, 449\u2013469. https:\/\/doi.org\/10.1017\/s0033291712000955 (2013).","journal-title":"Psychol. Med."},{"key":"40498_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.psyneuen.2005.02.010","volume":"30","author":"HM Burke","year":"2005","unstructured":"Burke, H. M., Davis, M. C., Otte, C. & Mohr, D. C. Depression and cortisol responses to psychological stress: A meta-analysis. Psychoneuroendocrinology 30, 846\u2013856. https:\/\/doi.org\/10.1016\/j.psyneuen.2005.02.010 (2005).","journal-title":"Psychoneuroendocrinology"},{"key":"40498_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.ajp.163.1.59","volume":"163","author":"JG Rabkin","year":"2006","unstructured":"Rabkin, J. G., McElhiney, M. C., Rabkin, R., McGrath, P. J. & Ferrando, S. J. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV\/AIDS. Am. J. Psychiatry 163, 59\u201366. https:\/\/doi.org\/10.1176\/appi.ajp.163.1.59 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"40498_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu, K. et al. Kynurenine pathway in depression: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 90, 16\u201325. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.023 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"40498_CR16","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12888-014-0372-y","volume":"14","author":"K Fukuda","year":"2014","unstructured":"Fukuda, K. Etiological classification of depression based on the enzymes of tryptophan metabolism. BMC Psychiatry 14, 372. https:\/\/doi.org\/10.1186\/s12888-014-0372-y (2014).","journal-title":"BMC Psychiatry"},{"key":"40498_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0167-4781(86)90032-1","volume":"867","author":"M Nagao","year":"1986","unstructured":"Nagao, M., Nakamura, T. & Ichihara, A. Developmental control of gene expression of tryptophan 2,3-dioxygenase in neonatal rat liver. Biochim. Biophys. Acta 867, 179\u2013186. https:\/\/doi.org\/10.1016\/0167-4781(86)90032-1 (1986).","journal-title":"Biochim. Biophys. Acta"},{"key":"40498_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0022-3956(96)00015-5","volume":"30","author":"P Hofmann","year":"1996","unstructured":"Hofmann, P. et al. 5-Hydroxy-indolacetic-acid (5-HIAA) serum levels in depressive patients and ECT. J. Psychiatry Res. 30, 209\u2013216. https:\/\/doi.org\/10.1016\/0022-3956(96)00015-5 (1996).","journal-title":"J. Psychiatry Res."},{"key":"40498_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.eurpsy.2008.03.003","volume":"23","author":"G Nikisch","year":"2008","unstructured":"Nikisch, G. & Math\u00e9, A. A. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy. Eur. Psychiatry 23, 356\u2013359. https:\/\/doi.org\/10.1016\/j.eurpsy.2008.03.003 (2008).","journal-title":"Eur. Psychiatry"},{"key":"40498_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","volume":"160","author":"G Sanacora","year":"2003","unstructured":"Sanacora, G. et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 160, 577\u2013579. https:\/\/doi.org\/10.1176\/appi.ajp.160.3.577 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"40498_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1017\/neu.2018.22","volume":"31","author":"MK Knudsen","year":"2019","unstructured":"Knudsen, M. K., Near, J., Blicher, A. B., Videbech, P. & Blicher, J. U. Magnetic resonance (MR) spectroscopic measurement of \u03b3-aminobutyric acid (GABA) in major depression before and after electroconvulsive therapy. Acta Neuropsychiatry 31, 17\u201326. https:\/\/doi.org\/10.1017\/neu.2018.22 (2019).","journal-title":"Acta Neuropsychiatry"},{"key":"40498_CR22","doi-asserted-by":"publisher","first-page":"e01833","DOI":"10.1002\/brb3.1833","volume":"10","author":"VJ Erchinger","year":"2020","unstructured":"Erchinger, V. J. et al. Anterior cingulate gamma-aminobutyric acid concentrations and electroconvulsive therapy. Brain Behav. 10, e01833. https:\/\/doi.org\/10.1002\/brb3.1833 (2020).","journal-title":"Brain Behav."},{"key":"40498_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/YCT.0b013e31815cbaa1","volume":"24","author":"E Esel","year":"2008","unstructured":"Esel, E. et al. The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J. ECT 24, 224\u2013228. https:\/\/doi.org\/10.1097\/YCT.0b013e31815cbaa1 (2008).","journal-title":"J. ECT"},{"key":"40498_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.psychres.2005.07.010","volume":"137","author":"J Palmio","year":"2005","unstructured":"Palmio, J. et al. Changes in plasma amino acids after electroconvulsive therapy of depressed patients. Psychiatry Res. 137, 183\u2013190. https:\/\/doi.org\/10.1016\/j.psychres.2005.07.010 (2005).","journal-title":"Psychiatry Res."},{"key":"40498_CR25","unstructured":"Appelbaum, P. S. & Grisso, T. MacArthur competence assessment tool for clinical research (MacCAT-CR). in Professional Resource Press\/Professional Resource Exchange (2001)."},{"key":"40498_CR26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013). https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"40498_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2013.10.043","volume":"156","author":"RS McIntyre","year":"2014","unstructured":"McIntyre, R. S. et al. Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach. J. Affect. Disord. 156, 1\u20137. https:\/\/doi.org\/10.1016\/j.jad.2013.10.043 (2014).","journal-title":"J. Affect. Disord."},{"key":"40498_CR28","doi-asserted-by":"publisher","first-page":"42434","DOI":"10.4088\/JCP.21m14293","volume":"83","author":"K Nakajima","year":"2022","unstructured":"Nakajima, K. et al. Individual prediction of remission based on clinical features following electroconvulsive therapy: A machine learning approach. J. Clin. Psychiatry 83, 42434 (2022).","journal-title":"J. Clin. Psychiatry"},{"key":"40498_CR29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery, S. A. & Asberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry J. Mental Sci. 134, 382\u2013389 (1979).","journal-title":"Br. J. Psychiatry J. Mental Sci."},{"key":"40498_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0006-3223(02)01866-8","volume":"54","author":"AJ Rush","year":"2003","unstructured":"Rush, A. J. et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol. Psychiatry 54, 573\u2013583. https:\/\/doi.org\/10.1016\/s0006-3223(02)01866-8 (2003).","journal-title":"Biol. Psychiatry"},{"key":"40498_CR31","first-page":"43","volume":"25","author":"D Fujisawa","year":"2010","unstructured":"Fujisawa, D. et al. Cross-cultural adaptation of the Quick inventory of depressive symptomatology, self-report (QIDS-SR-J). Jpn. J. Stress Sci. 25, 43\u201352 (2010) (in Japanese).","journal-title":"Jpn. J. Stress Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40498-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T22:21:30Z","timestamp":1700605290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40498"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40498-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.U. has received grants from the SENSHIN Medical Research Foundation (Osaka, Japan) within the past two years. M.M. has received speaker honoraria from Biogen Japan, Bayer Pharmaceuticals, Daiichi Sankyo, Dainippon-Sumitomo Pharma, Demant Japan, Eisai, Eli Lilly, Fuji Film RI Pharma, Hisamitsu Pharmaceutical, H.U. Frontier, Janssen Pharmaceutical, Mochida Pharmaceutical, MSD, Mylan EPD, Nippon Chemipher, Novartis Pharma, Ono Yakuhin, Otsuka Pharmaceutical, Pfizer, Shionogi, Takeda Yakuhin, Teijin Pharma, and Viatris in the past two years. He has also received grants from Daiichi Sankyo, Eisai, Fronteo, Shionogi, Takeda, Tanabe Mitsubishi, and Tsumura within the past two years outside of the submitted work. H.U. has received grants from Daiichi Sankyo, Eisai, Mochida, Otsuka, and Sumitomo Pharma; speaker fees from Eisai, Janssen, Lundbeck, Meiji Seika Pharma, Otsuka, and Sumitomo Pharma; and advisory board fees from Lundbeck, Sumitomo Pharma, Takeda Pharmaceutical Company, and Boehringer Ingelheim Japan. Y.S., E.S., R.M., K.T., and M.S. have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13218"}}